These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18565625)

  • 1. [Treatment of proliferative glomerulonephritis of systemic lupus erythematosus. Recent development and current recommendations].
    Daugas E
    Rev Med Interne; 2008 Sep; 29(9):710-7. PubMed ID: 18565625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential therapies for proliferative lupus nephritis.
    Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
    N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lupus nephritis: up-to-date].
    Karras A
    Rev Med Interne; 2015 Feb; 36(2):98-106. PubMed ID: 25443980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
    Chan TM; Li FK; Tang CS; Wong RW; Fang GX; Ji YL; Lau CS; Wong AK; Tong MK; Chan KW; Lai KN
    N Engl J Med; 2000 Oct; 343(16):1156-62. PubMed ID: 11036121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical guideline for the treatment of lupus nephritis and single-centre results of mycofenolate mofetil among patients with lupus nephritis in the National Institute of Rheumatology and Physiotherapy, Budapest].
    Szabó MZ; Kiss E
    Orv Hetil; 2016 Aug; 157(35):1385-93. PubMed ID: 27569461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
    Ginzler EM; Dooley MA; Aranow C; Kim MY; Buyon J; Merrill JT; Petri M; Gilkeson GS; Wallace DJ; Weisman MH; Appel GB
    N Engl J Med; 2005 Nov; 353(21):2219-28. PubMed ID: 16306519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro: Cyclophosphamide in lupus nephritis.
    Kallenberg CG
    Nephrol Dial Transplant; 2016 Jul; 31(7):1047-52. PubMed ID: 27190359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide treatment in systemic necrotizing vasculitis and lupus nephritis. How long? How much?
    Beimler JH; Andrassy K
    Pediatr Nephrol; 2004 Sep; 19(9):949-55. PubMed ID: 15257454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New treatment strategies for proliferative lupus nephritis: keep children in mind!
    Ranchin B; Fargue S
    Lupus; 2007; 16(8):684-91. PubMed ID: 17711908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of chlorambucil, azathioprine or cyclophosphamide combined with corticosteroids in the treatment of lupus nephritis.
    Sabbour MS; Osman LM
    Br J Dermatol; 1979 Feb; 100(2):113-25. PubMed ID: 85455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment options for severe lupus nephritis.
    Lenz O; Contreras G
    Arch Immunol Ther Exp (Warsz); 2004; 52(5):356-65. PubMed ID: 15507877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
    Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; Garrido Ed Ede R; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
    Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the management of lupus nephritis: let the treatment fit the patient.
    Bertsias G; Boumpas DT
    Nat Clin Pract Rheumatol; 2008 Sep; 4(9):464-72. PubMed ID: 18756272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lupus nephritis].
    Raimbourg Q; Daugas É
    Nephrol Ther; 2019 Jun; 15(3):174-189. PubMed ID: 30738732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.
    Austin HA; Klippel JH; Balow JE; le Riche NG; Steinberg AD; Plotz PH; Decker JL
    N Engl J Med; 1986 Mar; 314(10):614-9. PubMed ID: 3511372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.
    Buratti S; Szer IS; Spencer CH; Bartosh S; Reiff A
    J Rheumatol; 2001 Sep; 28(9):2103-8. PubMed ID: 11550982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Treatment With Multitarget Therapy of Mycophenolate Mofetil and Tacrolimus for Cyclophosphamide-Resistant Antineutrophil Cytoplasmic Antibody-Associated Pauci-Immune Glomerulonephritis Developed Independently of Systemic Lupus Erythematosus.
    Terasaki M; Takahashi H; Sato R; Okamoto S; Terasaki T; Toko H; Yagishita M; Hagiawara S; Kondo Y; Tsuboi H; Matsumoto I; Sumida T
    J Clin Rheumatol; 2021 Mar; 27(2):e79-e80. PubMed ID: 31895115
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytotoxic drug treatment of lupus nephritis.
    Donadio JV; Holley KE; Ilstrup DM
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):178-81. PubMed ID: 7102666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil in lupus glomerulonephritis: effectiveness and tolerability.
    Iaccarino L; Arienti S; Rampudda M; Canova M; Atzeni F; Sarzi Puttini P; Doria A
    Ann N Y Acad Sci; 2007 Sep; 1110():516-24. PubMed ID: 17911467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil for remission induction in severe lupus nephritis.
    Cross J; Dwomoa A; Andrews P; Burns A; Gordon C; Main J; Mathieson P; O'Donoghue D; Jayne D;
    Nephron Clin Pract; 2005; 100(3):c92-100. PubMed ID: 15824513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.